Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
- PMID: 9916135
- PMCID: PMC407888
- DOI: 10.1172/JCI5487
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
Abstract
beta3 integrins have been implicated in a wide variety of functions, including platelet aggregation and thrombosis (alphaIIbbeta3) and implantation, placentation, angiogenesis, bone remodeling, and tumor progression (alphavbeta3). The human bleeding disorder Glanzmann thrombasthenia (GT) can result from defects in the genes for either the alphaIIb or the beta3 subunit. In order to develop a mouse model of this disease and to further studies of hemostasis, thrombosis, and other suggested roles of beta3 integrins, we have generated a strain of beta3-null mice. The mice are viable and fertile, and show all the cardinal features of GT (defects in platelet aggregation and clot retraction, prolonged bleeding times, and cutaneous and gastrointestinal bleeding). Implantation appears to be unaffected, but placental defects do occur and lead to fetal mortality. Postnatal hemorrhage leads to anemia and reduced survival. These mice will allow analyses of the other suggested functions of beta3 integrins and we report that postnatal neovascularization of the retina appears to be beta3-integrin-independent, contrary to expectations from inhibition experiments.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/407888/bin/JCI9905487.f7.gif)
Similar articles
-
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.Expert Rev Hematol. 2012 Oct;5(5):487-503. doi: 10.1586/ehm.12.46. Expert Rev Hematol. 2012. PMID: 23146053 Review.
-
Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.Blood. 2011 Dec 1;118(23):5996-6005. doi: 10.1182/blood-2011-07-365635. Epub 2011 Sep 13. Blood. 2011. PMID: 21917754 Review.
-
Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.Blood. 2005 Oct 15;106(8):2671-9. doi: 10.1182/blood-2004-12-4619. Epub 2005 Jun 21. Blood. 2005. PMID: 15972454 Free PMC article.
-
Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia.Blood. 2000 Jun 15;95(12):3645-51. Blood. 2000. PMID: 10845892
-
A Ser162-->Leu mutation within glycoprotein (GP) IIIa (integrin beta3) results in an unstable alphaIIbbeta3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia.Thromb Haemost. 1998 Jul;80(1):42-8. Thromb Haemost. 1998. PMID: 9684783
Cited by
-
Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity.J Immunol. 2024 Jun 1;212(11):1680-1692. doi: 10.4049/jimmunol.2300290. J Immunol. 2024. PMID: 38607278
-
A novel ITGA2B double cytosine frameshift variant (c.1986_1987insCC) leads to Glanzmann's thrombasthenia in a cat.J Vet Intern Med. 2024 May-Jun;38(3):1408-1417. doi: 10.1111/jvim.17030. Epub 2024 Mar 1. J Vet Intern Med. 2024. PMID: 38426552 Free PMC article.
-
GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex.Biomolecules. 2023 Dec 27;14(1):38. doi: 10.3390/biom14010038. Biomolecules. 2023. PMID: 38254638 Free PMC article.
-
Mesenchymal stem cell-derived apoptotic bodies alleviate alveolar bone destruction by regulating osteoclast differentiation and function.Int J Oral Sci. 2023 Dec 1;15(1):51. doi: 10.1038/s41368-023-00255-y. Int J Oral Sci. 2023. PMID: 38040672 Free PMC article.
-
CD61 identifies a superior population of aged murine HSCs and is required to preserve quiescence and self-renewal.Blood Adv. 2024 Jan 9;8(1):99-111. doi: 10.1182/bloodadvances.2023011585. Blood Adv. 2024. PMID: 37939263 Free PMC article.
References
-
- Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11–25. - PubMed
-
- Kieffer N, Phillips DR. Platelet membrane glycoproteins: functions in cellular interactions. Annu Rev Cell Biol. 1990;6:329–357. - PubMed
-
- Shattil SJ. Function and regulation of the β3 integrins in hemostasis and vascular biology. Thromb Haemost. 1995;74:149–155. - PubMed
-
- Du X, Ginsberg MH. Integrin αIIbβ3 and platelet function. Thromb Haemost. 1997;78:96–100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous